Li-na Wang

Guangzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia.

Case Report: Safety and efficacy of blinatumomab in combination with donor lymphocyte infusion for the prophylaxis of relapse following allogeneic hematopoietic stem cell transplantation in a pediatric patient with acute lymphoblastic leukemia.

Journal: Frontiers in immunology
Published: March 08, 2026

CD71 as an independent prognostic factor in pediatric B-ALL: a regional multicenter retrospective study in Southern China (SCCLG-ALL-2016).

CD71 as an independent prognostic factor in pediatric B-ALL: a regional multicenter retrospective study in Southern China (SCCLG-ALL-2016).

Journal: Therapeutic advances in medical oncology
Published: December 10, 2025

Incidence, clinical features and risk factors of interstitial pneumonia in children with acute lymphoblastic leukemia.

Incidence, clinical features and risk factors of interstitial pneumonia in children with acute lymphoblastic leukemia.

Journal: Annals of hematology
Published: November 26, 2025

Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort.

Early Identification of Differentiation Syndrome During ATRA and Arsenic Therapy in Pediatric NHR-APL: Insights From a 14-Year Multicenter Cohort.

Journal: Pharmacoepidemiology and drug safety
Published: October 17, 2025

Impact of mercaptopurine schedule on hypoglycemia in leukemic children: randomized trial and risk factor analysis.

Impact of mercaptopurine schedule on hypoglycemia in leukemic children: randomized trial and risk factor analysis.

Journal: Pediatric research
Published: September 01, 2025

Glycyrrhizin Alleviates Puromycin Aminonucleoside-Induced Podocyte Injury via Regulating Autophagy and GSDMD-Dependent Pyroptosis.

Glycyrrhizin Alleviates Puromycin Aminonucleoside-Induced Podocyte Injury via Regulating Autophagy and GSDMD-Dependent Pyroptosis.

Journal: Critical reviews in eukaryotic gene expression
Published: June 18, 2025

A multicenter study on the prognostic value of prednisone response in pediatric acute lymphoblastic leukemia.

A multicenter study on the prognostic value of prednisone response in pediatric acute lymphoblastic leukemia.

Journal: Annals of hematology
Published: February 08, 2025

MG132 inhibits proliferation and induces apoptosis of acute lymphoblastic leukemia via Akt/FOXO3a/Bim pathway.

MG132 inhibits proliferation and induces apoptosis of acute lymphoblastic leukemia via Akt/FOXO3a/Bim pathway.

Journal: Human & experimental toxicology
Published: November 25, 2024

Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL group.

Prognostic significance of MRD and its correlation with arsenic concentration in pediatric acute promyelocytic leukemia: a retrospective study by SCCLG-APL group.

Journal: Therapeutic advances in hematology
Published: August 09, 2024

miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.

miR-133a and miR-135a Regulate All-Trans Retinoic Acid-Mediated Differentiation in Pediatric Acute Myeloid Leukemia by Inhibiting CDX2 Translation and Serve as Prognostic Biomarkers.

Journal: Technology in cancer research & treatment
Published: May 02, 2024

Induction treatments with and without addition of one dose anthracycline to all-trans retinoid acid and arsenic in pediatric non-high-risk acute promyelocytic leukemia: study protocol for a randomized controlled trial.

Induction treatments with and without addition of one dose anthracycline to all-trans retinoid acid and arsenic in pediatric non-high-risk acute promyelocytic leukemia: study protocol for a randomized controlled trial.

Journal: Trials
Published: January 18, 2024

The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia.

The Potential Transcriptomic and Metabolomic Mechanisms of ATO and ATRA in Treatment of FLT3-ITD Acute Myeloid Leukemia.

Journal: Technology in cancer research & treatment
Published: January 05, 2024
Showing 1-12 of 31

Last Updated: 09/26/2026